Clinical development sglt2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy15

Cell Line, Tumor Jejunum Kidney Microvilli Intestine, Small Kidney Tubules, Proximal Tumor Cells, Cultured HCT116 Cells LLC-PK1 Cells Oocytes HT29 Cells Cell Line Cells, Cultured Intestines Leukocytes, Mononuclear

Organisms14

Mice, Nude Camptotheca Macaca fascicularis Mice, SCID Dogs Rabbits Mice, Inbred BALB C Xenopus laevis Rats, Sprague-Dawley Mice, Inbred C57BL Hepacivirus HIV-1 Cricetinae Mice, Knockout

Diseases22

Neoplasms Glycosuria Drug-Related Side Effects and Adverse Reactions Disease Models, Animal Neovascularization, Pathologic Breast Neoplasms Lung Neoplasms Glycosuria, Renal Neoplasms, Experimental Prostatic Neoplasms Melanoma Carcinoma, Non-Small-Cell Lung Diabetes Mellitus, Type 2 Carcinoma, Renal Cell Multiple Myeloma Glioblastoma Ovarian Neoplasms Malaria, Falciparum Disease Progression Colonic Neoplasms Leukemia, Lymphocytic, Chronic, B-Cell Kidney Neoplasms

Chemicals and Drugs116

Sodium-Glucose Transporter 1 Sodium-Glucose Transporter 2 Drugs, Investigational Phlorhizin Antineoplastic Agents Monosaccharide Transport Proteins Methylglucosides Protein Kinase Inhibitors Glucosides Maytansine Antibodies, Monoclonal Glucose Glucose Transporter Type 2 Picolines Enzyme Inhibitors Angiogenesis Inhibitors Quinazolines Glucose Transporter Type 5 Pyrimidines Hypoglycemic Agents Prodrugs Epothilones Thiophenes Piperidines Tubulin Modulators Biomarkers, Pharmacological Pyrazoles Quinolines Membrane Glycoproteins Malaria Vaccines Antibodies, Monoclonal, Humanized Heterocyclic Compounds, 3-Ring TOR Serine-Threonine Kinases Benzodioxoles Immunoconjugates Receptor, Epidermal Growth Factor Cancer Vaccines Antiviral Agents Topoisomerase I Inhibitors Pyridines Receptors, Vascular Endothelial Growth Factor Antineoplastic Agents, Phytogenic Triazoles Sodium Pyrroles HIV Integrase Inhibitors Histone Deacetylase Inhibitors Benzimidazoles Indoles Thiazoles Camptothecin Phenylurea Compounds Piperazines Nitroimidazoles Glucose Transport Proteins, Facilitative Phosphatidylinositol 3-Kinase Benzamides Aminopyridines Sulfonamides Pyridones Antibodies, Bispecific Quinolones Protease Inhibitors Immunologic Factors Single-Chain Antibodies Vaccines Poly(ADP-ribose) Polymerases Pyrazines Oligopeptides Recombinant Proteins Biological Products Hydroxamic Acids Indazoles Oxazoles HSP90 Heat-Shock Proteins RNA, Messenger Sirolimus Carbamates Triazines Proto-Oncogene Proteins c-met Drug Combinations Drug Carriers Receptor, erbB-2 Diuretics, Osmotic Vascular Endothelial Growth Factor A Tumor Markers, Biological Immunotoxins Anti-Bacterial Agents Proto-Oncogene Proteins c-akt Phosphatidylinositol 3-Kinases Antibiotics, Antineoplastic Polyethylene Glycols Phosphodiesterase Inhibitors Protein-Tyrosine Kinases Anti-HIV Agents Imidazoles Reverse Transcriptase Inhibitors Biological Markers Sucrase Pharmaceutical Preparations Symporters Adjuvants, Immunologic Membrane Proteins Paclitaxel Benzhydryl Compounds Viral Nonstructural Proteins Antigens, Neoplasm Peptides Nitriles Vaccines, Synthetic Glycosides Taxoids Glucagon-Like Peptide 1 Morpholines Anticoagulants Proto-Oncogene Proteins c-bcl-2

Analytical, Diagnostic and Therapeutic Techniques and Equipment46

Clinical Trials as Topic Drug Evaluation, Preclinical Drug Discovery Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Clinical Trials, Phase III as Topic Drug Design Molecular Targeted Therapy Xenograft Model Antitumor Assays Drug Approval Administration, Oral Therapies, Investigational Drug Delivery Systems Inhibitory Concentration 50 Technology, Pharmaceutical Drug Screening Assays, Antitumor Immunotherapy Treatment Outcome Models, Biological Drug Administration Schedule Randomized Controlled Trials as Topic Area Under Curve Disease Models, Animal Tumor Burden Individualized Medicine Research Design Drug Evaluation Endpoint Determination Double-Blind Method Blotting, Western Genetic Therapy Infusions, Intravenous Drug Therapy, Combination Neoplasm Transplantation Toxicity Tests Neoplasms, Experimental Protein Engineering Drug Carriers Transplantation, Heterologous Antineoplastic Combined Chemotherapy Protocols Models, Molecular Metabolic Clearance Rate Microbial Sensitivity Tests Maximum Tolerated Dose Transfection Immunohistochemistry

Phenomena and Processes35

Dose-Response Relationship, Drug Inhibitory Concentration 50 Drug Resistance, Neoplasm Signal Transduction Molecular Structure Biological Availability Cell Proliferation Area Under Curve Apoptosis Drug Synergism Tissue Distribution Drug Resistance, Viral Mutation Intestinal Absorption Half-Life Pharmacokinetics Antibody-Dependent Cell Cytotoxicity Time Factors Drug Interactions Replicon Structure-Activity Relationship Biological Transport Cell Cycle Cell Survival Protein Binding Gene Expression Regulation, Neoplastic Biotransformation Kinetics Metabolic Clearance Rate Phosphorylation Absorption Maximum Tolerated Dose Cell Division Transfection Genetic Vectors

Disciplines and Occupations11

Drug Discovery Drug Design Pharmacology, Clinical Technology, Pharmaceutical Translational Medical Research Individualized Medicine Research Design Medical Oncology Chemistry, Pharmaceutical Biomedical Research Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Technology, Industry, Agriculture4

Drug Industry Technology, Pharmaceutical Nanoparticles Polyethylene Glycols

Information Science1

Molecular Sequence Data

Health Care11

Clinical Trials as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Clinical Trials, Phase III as Topic Treatment Outcome Randomized Controlled Trials as Topic Area Under Curve United States Food and Drug Administration Double-Blind Method Guidelines as Topic Safety

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Health Care

Sodium-Glucose Transporter 1 Sodium-Glucose Transporter 2 Clinical Trials as Topic Drugs, Investigational Phlorhizin Antineoplastic Agents Neoplasms Drug Evaluation, Preclinical Drug Discovery Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Clinical Trials, Phase III as Topic Drug Design Glycosuria Monosaccharide Transport Proteins Methylglucosides Protein Kinase Inhibitors Glucosides Molecular Targeted Therapy Xenograft Model Antitumor Assays Dose-Response Relationship, Drug Cell Line, Tumor Maytansine Drug Approval Antibodies, Monoclonal Pharmacology, Clinical Mice, Nude Glucose Glucose Transporter Type 2 Picolines Administration, Oral Enzyme Inhibitors Therapies, Investigational Drug Industry Angiogenesis Inhibitors Drug Delivery Systems Camptotheca Quinazolines Inhibitory Concentration 50 Drug Resistance, Neoplasm Glucose Transporter Type 5 Macaca fascicularis Technology, Pharmaceutical Drug Screening Assays, Antitumor Pyrimidines Translational Medical Research Hypoglycemic Agents Prodrugs Epothilones Thiophenes Piperidines Tubulin Modulators Biomarkers, Pharmacological Jejunum Pyrazoles Quinolines Immunotherapy Signal Transduction Treatment Outcome Membrane Glycoproteins Molecular Structure Malaria Vaccines Biological Availability Antibodies, Monoclonal, Humanized Heterocyclic Compounds, 3-Ring TOR Serine-Threonine Kinases Benzodioxoles Immunoconjugates Cell Proliferation Receptor, Epidermal Growth Factor Cancer Vaccines Antiviral Agents Models, Biological Drug Administration Schedule Drug-Related Side Effects and Adverse Reactions Randomized Controlled Trials as Topic Area Under Curve Topoisomerase I Inhibitors Pyridines Receptors, Vascular Endothelial Growth Factor Apoptosis Antineoplastic Agents, Phytogenic Disease Models, Animal Triazoles Sodium Kidney Pyrroles HIV Integrase Inhibitors Histone Deacetylase Inhibitors Tumor Burden Benzimidazoles Drug Synergism Indoles Individualized Medicine Neovascularization, Pathologic Thiazoles Camptothecin Research Design Tissue Distribution Phenylurea Compounds

No FAQ available that match "clinical development sglt2"